BE903694A - Procede de preparation de silibinine depourvue d'isosilybine et medicaments renfermant de la silibinine. - Google Patents

Procede de preparation de silibinine depourvue d'isosilybine et medicaments renfermant de la silibinine.

Info

Publication number
BE903694A
BE903694A BE2/60851A BE2060851A BE903694A BE 903694 A BE903694 A BE 903694A BE 2/60851 A BE2/60851 A BE 2/60851A BE 2060851 A BE2060851 A BE 2060851A BE 903694 A BE903694 A BE 903694A
Authority
BE
Belgium
Prior art keywords
silibinin
preparation
free
isibilybine
medicinal products
Prior art date
Application number
BE2/60851A
Other languages
English (en)
Inventor
R Madaus
K Gorler
H Soicke
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of BE903694A publication Critical patent/BE903694A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L59/00—Thermal insulation in general
    • F16L59/04—Arrangements using dry fillers, e.g. using slag wool which is added to the object to be insulated by pouring, spreading, spraying or the like

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Préparation de la silibinine exempte d'isosilybine à partir de fruits séchés de Silybum marianum L. Gaertn. dont on extrait, de façon connue, une poudre brunatre, à la suite de quoi on sépare la silibinine en plusieurs étapes faisant intervenir des traitements par le méthanol et l'acétate d'éthyle, dans des conditions bien déterminées. Application à la préparation de médicaments pour le traitement et la prévention des troubles hépatiques.
BE2/60851A 1984-11-22 1985-11-22 Procede de preparation de silibinine depourvue d'isosilybine et medicaments renfermant de la silibinine. BE903694A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3442641 1984-11-22
DE19853537656 DE3537656A1 (de) 1984-11-22 1985-10-23 Verfahren zur herstellung von isosilybinfreiem silibinin und arzneimittel, enthaltend silibinin

Publications (1)

Publication Number Publication Date
BE903694A true BE903694A (fr) 1986-05-22

Family

ID=25826741

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/60851A BE903694A (fr) 1984-11-22 1985-11-22 Procede de preparation de silibinine depourvue d'isosilybine et medicaments renfermant de la silibinine.

Country Status (26)

Country Link
US (1) US4871763A (fr)
JP (1) JPH0678228B2 (fr)
AR (1) AR241268A1 (fr)
AT (1) AT391315B (fr)
BE (1) BE903694A (fr)
CA (1) CA1337125C (fr)
CH (1) CH660008A5 (fr)
CS (1) CS271321B2 (fr)
DE (1) DE3537656A1 (fr)
DK (3) DK166541B1 (fr)
EG (1) EG17710A (fr)
ES (2) ES8609312A1 (fr)
FI (1) FI84065C (fr)
FR (1) FR2573426B1 (fr)
GB (1) GB2167746B (fr)
HU (1) HU195504B (fr)
IE (1) IE59209B1 (fr)
IT (1) IT1207508B (fr)
LU (1) LU86164A1 (fr)
MX (1) MX172175B (fr)
NL (1) NL192204C (fr)
NO (1) NO160206C (fr)
PL (1) PL146889B1 (fr)
PT (1) PT81531B (fr)
SE (1) SE457957B (fr)
YU (1) YU43690B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
DE4401902C2 (de) * 1994-01-24 2000-02-03 Madaus Ag Verwendung von Flavolignanen als Adjuvans in der Tumortherapie
FR2719451B1 (fr) * 1994-05-04 1996-07-26 Apcis Sa Utilisation de la silybinine dans le gavage des palmipèdes, en vue de l'obtention d'un foie gras de meilleure qualité.
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
DE69824223T2 (de) 1997-03-19 2004-09-30 Unilever N.V. Vorrichtung zum Handhaben von Gegenständen
GB2327607B8 (en) * 1997-07-31 2005-03-30 Litton Internat Company Ltd A process for producing a herbal extract composition
DE10053384A1 (de) * 2000-10-27 2002-05-08 Bionorica Arzneimittel Gmbh Pharmazeutische Zubereitung aus Mariendistel und Terpenen
US6699900B2 (en) * 2001-04-07 2004-03-02 Jan E. Zielinski Hydrophilic and lipophilic silibinin pro-forms
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
BG65997B1 (bg) * 2005-03-29 2010-09-30 "Софарма" Ад Метод за получаване на силибинин
ES2374117T3 (es) * 2007-11-15 2012-02-13 Madaus Gmbh Componente de silibinina para el tratamiento de la hepatitis.
CA2761656C (fr) 2009-05-14 2017-02-07 Lucio Claudio Rovati Silibinine amorphe pour le traitement d'une hepatite virale
WO2011051742A1 (fr) 2009-10-28 2011-05-05 Modutech S.A. Préparation comprenant des acides aminés et des plantes et son activité dans la détoxification d'alcool
CN103408539B (zh) * 2013-08-28 2016-04-06 天津泰阳制药有限公司 高纯度水飞蓟宾的生产方法
CN109071482A (zh) * 2016-01-15 2018-12-21 汉堡大学 携有o-鼠李糖基残基的类黄酮型化合物
US20240024399A1 (en) 2020-09-29 2024-01-25 Munisekhar Medasani Bioactive compounds extraction from plant matters of silybum marianum and usage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923082C3 (de) * 1969-05-06 1985-08-22 Dr. Madaus & Co, 5000 Koeln Verfahren zur Gewinnung von Polyhydroxyphenylchromanonen (Silymarin I-IV) und Arzneimittel enthaltend das Polyhydroxyphenylchromanon (Silymarin I-IV = Silymarin I-IV-Gruppe)Gemisch
US3773932A (en) * 1968-06-01 1973-11-20 Madaus & Co Dr Method for recovering silymarin comprising polyhydroxyphenyl chromanones
DE1767666C3 (de) * 1968-06-01 1986-07-31 Dr. Madaus & Co, 5000 Koeln Pharmazeutische Zubereitung gegen Lebererkrankungen
DE2416302B2 (de) * 1974-04-04 1978-02-02 Dr. Madaus & Co, 5000 Köln Dimeres sowie trimeres silybin und deren n-methylglucaminsalz und verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
BE885558A (fr) * 1980-10-07 1981-04-07 Madaus & Co Dr Procede pour l'extraction de silymarine a partir des plantes silymarine ainsi obtenue et son utilisation en therapeutique
DE3225688A1 (de) * 1982-07-09 1984-01-12 Suschnik Matthias Dr Verfahren zur gewinnung von silymarin aus silybum marianum

Also Published As

Publication number Publication date
FR2573426B1 (fr) 1988-06-10
AT391315B (de) 1990-09-25
SE8505488D0 (sv) 1985-11-20
CS837985A2 (en) 1990-02-12
FI854536A0 (fi) 1985-11-18
FI84065B (fi) 1991-06-28
YU181285A (en) 1987-12-31
SE8505488L (sv) 1986-05-23
PL256373A1 (en) 1986-12-02
US4871763A (en) 1989-10-03
ES8609312A1 (es) 1986-09-01
PL146889B1 (en) 1989-03-31
DK537685D0 (da) 1985-11-21
HU195504B (en) 1988-05-30
NL192204B (nl) 1996-11-01
GB2167746B (en) 1989-01-11
CA1337125C (fr) 1995-09-26
DK166541B1 (da) 1993-06-07
NO160206C (no) 1989-03-22
EG17710A (en) 1990-10-30
DE3537656C2 (fr) 1989-03-16
DK164866C (da) 1993-01-18
FI854536A (fi) 1986-05-23
LU86164A1 (de) 1986-03-24
GB2167746A (en) 1986-06-04
GB8527809D0 (en) 1985-12-18
AR241268A1 (es) 1992-04-30
NO160206B (no) 1988-12-12
CH660008A5 (de) 1987-03-13
NL8503136A (nl) 1986-06-16
FI84065C (fi) 1991-10-10
JPH05271071A (ja) 1993-10-19
NO854657L (no) 1986-05-23
ES549119A0 (es) 1986-09-01
FR2573426A1 (fr) 1986-05-23
IE59209B1 (en) 1994-01-26
IT8522933A0 (it) 1985-11-21
IT1207508B (it) 1989-05-25
PT81531B (pt) 1987-11-11
DE3537656A1 (de) 1986-05-22
PT81531A (de) 1985-12-01
ES554022A0 (es) 1987-04-01
SE457957B (sv) 1989-02-13
CS271321B2 (en) 1990-09-12
IE852927L (en) 1986-05-22
DK114592A (da) 1992-09-17
MX172175B (es) 1993-12-07
DK114592D0 (da) 1992-09-17
DK537685A (da) 1986-05-23
DK172879B1 (da) 1999-09-06
DK164866B (da) 1992-08-31
ES8704482A1 (es) 1987-04-01
DK189491A (da) 1991-11-20
HUT40115A (en) 1986-11-28
DK189491D0 (da) 1991-11-20
YU43690B (en) 1989-10-31
JPH0678228B2 (ja) 1994-10-05
ATA337285A (de) 1990-03-15
NL192204C (nl) 1997-03-04

Similar Documents

Publication Publication Date Title
BE903694A (fr) Procede de preparation de silibinine depourvue d'isosilybine et medicaments renfermant de la silibinine.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
RU2122409C1 (ru) Лечение жирными кислотами
PT64840B (fr) Procede de preparation d'esteres aralquiliques d'acide 1,4-dihydrapiridinocarboxilique a effet coronaire et antihypertensive application des memes pour la preparation de compositions pharmaceutiques a effet coronaire et antihypertensive et application de ces compositions pharmaceutiques pour le traitement de maladies de lacirculation sanguine
KR880010764A (ko) 과콜레스테롤혈중 치료용 혼합물
MXPA01007662A (es) Epa de etilo altamente purificado y otros derivados de epa para desordenes psiquiatricos y neurologicos.
NO931267D0 (no) Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin
CA2386215C (fr) Procede de traitement des insuffisances veineuses chroniques a l'aide d'un extrait de feuilles de vigne rouge
RU2006127272A (ru) Применение комплексов гинкго для усиления когнитивных функций и снижения умственного утомления
AU598853B2 (en) Therapeutic composition comprising gamma-linolenic acid and calcium
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
KR930001902A (ko) 지방산의 약물의 제조방법
CA2035951A1 (fr) Derives de bilobalide, leurs applications, et formulations en contenant
EP0257081A1 (fr) Procede permettant de modifier la structure lipidique des membranes cellulaires et compositions pharmaceutiques utilisees a cet effet
CA2340227C (fr) Procede et composition pharmaceutique destines a reduire la concentration plasmatique d'homocysteine
TNSN00186A1 (fr) Une composition pour la prevention et/ou le traitement des troubles circulatoires comportant des derives de l-carnitine et des extraits de ginkgo biloba
JPS58159418A (ja) 医薬組成物
US5324748A (en) Method for enhancement of 1-series PG production
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
KR920000892B1 (ko) 각화증 치료제
JPH08208501A (ja) ガルシニア マンゴスタナｌ．の抽出物を含有する抗ヘリコバクター・ピロリ薬
FR2447368A1 (fr) Derives de la phenylethylamine, leur preparation et medicament contenant ces substances
RU2077888C1 (ru) Способ лечения лучевой болезни у животных
EP0261891A3 (fr) Compositions pharmaceutiques contenant de l'étiochiolandione
Murty Clinical toxicity study of Semecarpus anacardium Linn. f

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DR. MADAUS G.M.B.H. & CO.

Effective date: 20011130